NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
Buyer
NHS ENGLAND
Value
£250,000,000
Published
15 Dec 2021
Closes
15 Dec 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33141510
Blood products
Lots
Lot default NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B
£250,000,000
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options...
Delivery: Guernsey, Isle of Man, Jersey, United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
21 Oct 2021
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.